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A B S T R A C T
Purpose: Epilepsy is highly prevalent in people with intellectual disabilities and mortality is increased in
people with epilepsy generally. This review summarises research on the comparative risk of mortality in
people with intellectual disabilities and epilepsy compared to the general population, people with
intellectual disabilities without epilepsy, and people with epilepsy without intellectual disabilities.
Method: Studies were identiﬁed via electronic searches using Medline, Cinahl and PsycINFO and cross-
citations. Information extracted from studies was tabulated and reviewed narratively.
Results: Sixteen studies met the inclusion criteria. Epilepsy was associated with increased mortality in
people with intellectual disabilities in most studies, particularly in those experiencing recent seizures.
Further research is needed to substantiate some of the reported ﬁndings.
Conclusion: Services must be equipped with the skills and information needed to manage this condition
in order to minimise the risk of death in people with intellectual disabilities and epilepsy.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy is one of the most common serious brain disorders,
affecting over 50 million people worldwide [1]. The prevalence of
epilepsy has been estimated at approximately 0.5–1.0% of the
general population [2–4]. In people with intellectual disabilities,
estimates of the prevalence of epilepsy vary due to differences in
the methods used and inherent population biases [5]. Despite this
variation, it is clear that the prevalence of epilepsy in people with
intellectual disabilities is much greater than in the general
population [6]. Reported rates range, for example, from 16.1% of
1595 people with intellectual disabilities identiﬁed in South Wales
[7] to 30.7% in a random sample of 753 people with intellectual
disabilities aged 40 or more from Ireland’s National Intellectual
Disability Database (NIDD) [8]. In a systematic review of the
prevalence of chronic health conditions in children with intellec-
tual disabilities, the most common condition was epilepsy [9] with
prevalence rates in the 14 studies identiﬁed ranging from 5.5% to
35.0%, with an overall weighted mean prevalence rate of 22.0%
(95% CI 20.8, 23.2).* Corresponding author. Tel.: +44 1524 592895; fax: +44 1524 592658.
E-mail address: j.m.robertson@lancaster.ac.uk (J. Robertson).
http://dx.doi.org/10.1016/j.seizure.2015.04.004
1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reMortality is increased in people with epilepsy, with a recent
systematic review and meta-analysis of 38 epilepsy cohorts
including over 165,000 patients ﬁnding a pooled relative risk of
death of 3.3 (95% CI 2.83, 3.92) compared to the general population
[10]. Risk of premature death was lowest in idiopathic epilepsy and
in people with epilepsy who had attained seizure freedom.
People with epilepsy may have elevated mortality from
external causes such as accidents including drowning [11].
However, Sudden Unexpected Death in Epilepsy (SUDEP) is the
most important category of epilepsy related death [12]. In the UK it
is estimated that 500 deaths per annum are SUDEP [13]. Overall
ﬁndings regarding the risk of SUDEP in people with intellectual
disabilities are inconsistent. One systematic review of risk factors
for SUDEP based on 27 studies found that ‘mental retardation’ was
not a risk factor for SUDEP [14]. However, it is not clear how many
studies in the review included intellectual disability as a risk factor.
A more recent review identiﬁed 23 articles which considered
intellectual disability and SUDEP of which 14 found intellectual
disability to be a risk factor for SUDEP and none found intellectual
disability to be a protective factor in SUDEP [15].
For people with intellectual disabilities, epilepsy or convulsions
has been identiﬁed as an important and to some extent potentially
preventable cause of death [16]. The study looked at ages and
causes of death recorded on death certiﬁcates for people withserved.
J. Robertson et al. / Seizure 29 (2015) 123–133124intellectual disabilities, or conditions that can cause intellectual
disabilities, who died between 2004 and 2008 in England. Epilepsy
or unspeciﬁed convulsions were involved in 948 deaths (13% of
those identiﬁable) of people with intellectual disabilities or
possibly associated conditions. In other people, they were involved
in 0.4%. Based on Standardised Mortality Odds Ratios (an
approximation of the Standardised Mortality Ratio), adjusting
for ages at death, people where death involved epilepsy or
unspeciﬁed convulsions were 9.7 times more likely than others to
have an intellectual disability-related condition (95% CI 9.1, 10.4).
The high prevalence of epilepsy in people with intellectual
disabilities, combined with the increased risk of mortality in
people with epilepsy, makes the topic of mortality in people with
intellectual disabilities and epilepsy a pertinent one. This review
aims to summarise studies on mortality in the general population
of people with intellectual disabilities and epilepsy and as such it
excludes studies on speciﬁc syndromes associated with intellec-
tual disabilities. However, the review does include information
relating to people with Down syndrome which is by far the most
common chromosomal disorder associated with intellectual
disability with a prevalence of approximately 1 in 700 live births
[17]. Most early studies of mortality in people with intellectual
disabilities and epilepsy were hospital based, with an early search
of the literature ﬁnding no population-based studies including all
types of intellectual disabilities on the inﬂuence of epilepsy on
mortality [18]. Since that time, further studies have been
conducted, including population-based studies. In this review,
we summarise existing research published from 1990 that
quantiﬁes the mortality of people with intellectual disabilities
and epilepsy using a comparative statistic relative to either the
general population, people with intellectual disabilities who do not
have epilepsy, or people with epilepsy who do not have intellectual
disabilities. The statistics reported are deﬁned in Table 1. For all of
these, a value of one implies no difference between the two
groups, a value of more than one indicates that the risk is greater in
the target group, and a value of less than one indicates that the risk
is less in the target group. For example, a hazard ratio of two
implies double the risk of dying in the target group than in the
comparison group. If the hazard ratio is 0.5 then the relative risk of
dying in the target group is half the risk of dying in the comparison
group. For all of these statistics, the value can be considered
statistically signiﬁcant at p < .05 if the 95% conﬁdence interval
does not include one.
2. Method
Electronic literature database searches were conducted in
Medline, Cinahl and PsycINFO on EBSCO. In addition, the referenceTable 1
Deﬁnitions for statistics reported.
Term Deﬁnition
Standardised mortality
ratio (SMR)
Number of observed deaths in the target
population divided by the number of deaths
that would be expected based on death rates of
a chosen standard population
Relative risk or risk ratio The risk of an event (e.g. death) in the target
population divided by the risk in the
comparison group
Hazard ratio A speciﬁc type of relative risk which is obtained
using the Cox Proportional Hazards Model, a
regression model that takes into account time
until the event occurs
Odds ratio The odds (number of times an event happens
divided by the number of times it does not
happen) of an event occurring in one group
divided by the odds of the same event in
another grouplists of articles meeting the inclusion criteria were searched and
articles from authors’ personal collections included. The reference
lists of key book chapters were also searched [19–21]). Searches
were completed on 19 June 2014. Searches included terms relating
to both mortality and prevalence to create a pool of articles on
mortality or prevalence, with articles on prevalence being retained
for a separate review. Searches combined terms for epilepsy,
intellectual disabilities, and mortality/prevalence with the Boolean
operator ‘AND’. Full details of the search terms are given in
Appendix One.
2.1. Inclusion criteria
 Peer reviewed.
 English language full text.
 Published from 1990; articles published before this date were
excluded as they predate both improvements in epilepsy
treatment and major changes in service provision for people
with intellectual disabilities [22].
 Primary research.
 Presents a comparative statistic (e.g. relative risk, standardised
mortality ratio (SMR), hazard ratio) on mortality in adults or
children with intellectual disability and epilepsy compared to
the general population, people with intellectual disability
without epilepsy, or people with epilepsy without intellectual
disability.
 Samples of adults or children with intellectual disabilities or
samples where 50% or more have intellectual disabilities or
mixed samples where results are disaggregated for people with
intellectual disabilities.
2.2. Exclusion criteria
 Case studies.
 Case series.
 Narrative reviews.
 Studies based on neonates (new born infants up to 28 days after
birth), all other age groups were included.
 Studies on conditions where intellectual disabilities cannot be
assumed (e.g. cerebral palsy, autistic spectrum disorder (ASD))
where results were not disaggregated for people with intellec-
tual disabilities.
 Studies on speciﬁc syndromes associated with intellectual
disabilities with the exception of Down syndrome. Less common
syndromes were excluded, such as Fragile X syndrome which has
a prevalence of 1 in 4000 males and 1 in 8000 females [23] and is
not always associated with intellectual disabilities [17].
 Does not present a comparative statistic approximating relative
risk (e.g. presents only descriptive statistics, presents chi-
squared analysis).
Initially, titles and abstracts were used to exclude those studies
which were obviously not within the scope of reviews on
prevalence or mortality. Those retained for further screening were
those for which relevance could not be assessed without accessing
full text, or those that were chosen as potentially within scope.
These studies were screened by the ﬁrst and second author and
discussed until consensus was reached on whether or not they met
the inclusion criteria in relation to mortality in people with
intellectual disabilities and epilepsy.
Where multiple articles used the same sample or samples were
likely to have considerable overlap (e.g. [24,25]), only the most
recent study was included unless the studies were looking at
different topics within the same sample (e.g. [29,25] are based on
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looks at whether seizure severity increases mortality).
Information from the included studies was extracted by the ﬁrst
author in relation to: authors; year of publication; country of
study; study design and study period; sample description;
deﬁnition of epilepsy; sample size and number of deaths for
those with intellectual disabilities and epilepsy; sample size and
number of deaths for any comparison group; group that people
with intellectual disabilities and epilepsy are compared to;
statistic used (e.g. SMR); and main results. This information was
tabulated (see Table 2). Formal quality assessments were not
undertaken as the intention was to include all studies reporting
relevant comparative statistics and as such the review does not
adhere to PRISMA guidelines [26]. However, elements of studies
relevant to quality and risk of bias (i.e. sample representativeness,
deﬁnition used for ascertainment of epilepsy, sample size) are
summarised for each study in Table 2. Differences in the main
characteristics of samples included in the studies and in the
deﬁnition of epilepsy used were such that it was not possible to
conduct meta-analysis to combine estimates of the risk of
mortality.
3. Results
The process of identifying studies for inclusion is summarised in
Fig. 1. Electronic database searches identiﬁed a total of 1332
references, with 1099 remaining after removal of duplicates.
Following the ﬁrst examination of studies, 144 remained in a pool
of articles relating to mortality or prevalence. After examination of
full text articles from this pool and the addition of articles cited
within these and from authors’ personal collections, 16 articles met
the criteria for inclusion in relation to mortality in people with
intellectual disabilities and epilepsy.
3.1. Country
All studies were from high income countries. There were ﬁve
studies based on samples from the United States [25,27–30]; four
from the United Kingdom (UK) [31,32,12,33]; three from Finland
[34–36]; and one from each of the Netherlands [37], Sweden [18],
Sweden and Denmark [38], and Japan [39]. The studies are
summarised in Table 2. Figures for 95% conﬁdence intervals are
given in parentheses after the point estimate.
3.2. Sample representativeness
Few studies were based on samples that could be considered
representative of the general population of people with intellectual
disabilities and epilepsy. Three studies were based on samples of
people with Down syndrome [37,32,38]. Two articles using the
same data source included those with mild developmental
disabilities [25,29]. One study included those with refractory
epilepsy [31]. Other studies were based on samples from speciﬁc
settings where samples may have been skewed towards those with
more severe epilepsy, including those attending one school for
those with epilepsy and intellectual disabilities [33], an institution
for those with the most severe disabilities [39], inpatients and
outpatients at one centre for people with intellectual disabilities
[34] and patients at three epilepsy centres [30].
Two studies included comprehensive samples of people with
epilepsy including those with and without intellectual disabilities.
One study ascertained all children with epilepsy in one US county
[28]. Similarly, one study ascertained all children with epilepsy in
the catchment area of one hospital [36]. One study used a
population-based cohort of people with developmental disabilities
but this study did not give exact details for the number of peoplewith intellectual disabilities and epilepsy in the sample, with the
result given in Table 2 relating to those with epilepsy and an
additional unspeciﬁed developmental disability [27]. Three studies
included representative samples of people with intellectual
disabilities both with and without epilepsy including all those
in one province of Finland [18], those on the Leicestershire
Intellectual Disability Register [12], and a nationwide population-
based sample from Finland [35].
3.3. All cause mortality in cohorts with intellectual disabilities:
comparison of those with or without epilepsy to the general population
In a small number of studies, ﬁgures are given in relation to all
cause mortality for people with intellectual disabilities compared
to the general population separately for those with and without
epilepsy, or the entire sample including both those with and
without epilepsy. For those with mild developmental disabilities
(excluding those unable to walk well or with degenerative
conditions), the SMR for those with remote symptomatic epilepsy
was 4.0 (95% CI 3.6, 4.3) compared to 1.9 (95% CI 1.8, 2.0) for those
without epilepsy [25]. For a representative sample of people with
intellectual disabilities from Sweden, the SMR was 5.0 (95% CI 3.3,
7.5) for those with intellectual disabilities and epilepsy compared
to 2.0 (95% CI 1.7, 2.3) for the entire sample [18]. In this latter study,
SMRs are also given in relation to seizure type and frequency:
seizure free in the preceding year 2.0 (95% CI 0.9, 4.7); seizures
weekly or fewer 4.7 (95% CI 2.8, 7.9); seizures more than weekly
16.8 (95% CI 10.7, 26.5); partial seizures without seizures
secondarily generalised 3.7 (95% CI 1.0, 13.6); seizures secondarily
generalised 5.0 (95% CI 2.3, 11.0); and seizures generalised from
onset 8.1 (95% CI 5.7, 11.5). In a sample from England, the SMRs for
people with intellectual disabilities and epilepsy were 3.2 (95% CI
2.7, 3.8) for men and 5.6 (95% CI 4.6, 6.7) for women, whilst the
overall SMRs for the entire sample were 2.2 (95% CI 2.0, 2.4) for
men and 2.8 (95% CI 2.5, 3.1) for women [12]. Finally, the SMR for
overall mortality in a study of pupils at one school for those with
severe epilepsy and intellectual disabilities compared to the
general population was 15.9 (95% CI 10.6, 23.0) [33].
3.4. All cause mortality in cohorts with intellectual disabilities:
comparison of those with and without epilepsy
More commonly, studies compare the mortality of people with
intellectual disabilities and epilepsy to people with intellectual
disabilities who do not have epilepsy in the same cohort. For
people with mild developmental disabilities (excluding those
unable to walk well or with degenerative conditions) and remote
symptomatic epilepsy, compared to those in the cohort without
epilepsy, SMRs were: 1.1 (95% CI 0.8, 1.5) for those who had not had
a seizure in the last year; 2.4 (95% CI 1.9, 3.0) for those who had had
seizures in the last year but not generalised tonic–clonic (GTC)
seizures; 2.9 (95% CI 2.4, 3.4) for those who had had GTC seizures in
the last year; and 3.7 (95% CI 2.5, 5.4) for those who had
experienced status epilepticus in the last year [29]. In this cohort,
those without epilepsy had an SMR of 1.7 (95% CI not stated)
compared to the general population. In a later analysis employing
the same sample source and exclusions, the overall ratio SMR (the
SMR for those with epilepsy divided by the SMR for those without
epilepsy) was 2.1 (95% CI 1.9, 2.3) [25].
In a cohort of inpatients and outpatients of one centre for people
with intellectual disabilities, the hazard ratio was 0.87 (95% CI 0.48,
1.61) for inpatients with epilepsy and 1.79 (95% CI 0.76, 4.25) for
outpatients with epilepsy [34]. When type of residence was
considered for outpatients, the risk of death due to status
epilepticus was more than doubled for those in hostels. In a
cohort living in one institution for people with severe intellectual
Table 2
Summary of studies on comparative risk of mortality in people with intellectual disabilities and epilepsy.
Author Country Design and study
period
Sample description Epilepsy
deﬁnition
Sample size
ID and epilepsy
Sample size
other group
Comparison
group
Statistic Results (and 95%
conﬁdence interval).
All cause mortality unless
otherwise stated
Coppus et al.
(2008) [37]
Netherlands Prospective
longitudinal cohort,
enrolled 1999–2003,
end date 1 January
2007
All with DS aged 45 or
more (n=499) living in
community or
institutions in four
regions
Epilepsy (past or
present) at
baseline
109 with epilepsy,
40 deaths
390c without
epilepsy, 69c
deaths
Those without
epilepsy in sample
Hazard ratio 2.29 (1.50, 3.48)
Not signiﬁcant in
multivariate survival analysis
Day et al.
(2005) [25]
(see also Strauss
et al., 2003 [29])
US Retrospective analysis
of records 1988–2002
People with mild DD
(deﬁned as disabling
condition closely related
to ID) receiving services
from State of California
Department of
Developmental Services.
Excluded more severe
disabilities (unable to
walk climb stairs without
support, severe or
profound ID,
degenerative conditions)
History of remote
symptomatic
epilepsy
(idiopathic
epilepsy excluded)
10,030 DD and
epilepsy
(65,126 person
years). 406
deaths
96,163 DD and no
epilepsy (656,632
person years). 1991
deaths
Those without
epilepsy in sample
Ratio SMR
(SMR those
with
epilepsy/SMR
those with no
epilepsy)
2.1 (1.9, 2.3).
Cause speciﬁc (based on ICD-
9 codes):
Epilepsy/seizures 53.1 (28.0,
101.0);
Convulsions 25.2 (11.7, 54.2);
Brain cancer 5.2 (2.2, 12.1),
Respiratory 1.7 (1.2, 2.5)
Aspiration pneumonia 3.0
(1.5, 6.0)
Circulatory diseases 1.3 (1.0,
1.7),
Suicides 1.5 (0.3, 6.5)
Accidents 2.7 (1.9, 3.7),
especially
Drowning 12.8 (7.0, 23.2).
Drowning those with recent
seizures 15.8 (7.2, 34.7)
As above
same study,
compared to
general
population
As above As above As above As above As above As above California
general
population (GP)
SMR DD and epilepsy 4.0 (3.6, 4.3)
DD no epilepsy 1.9 (1.8, 2.0)
Suicide DD and epilepsy 0.3
(ns)
Suicide DD no epilepsy 0.2
(ns)
Drowning those with recent
seizures 35.9 (ns)
Drowning no history of
epilepsy 2.3 (ns)
Decouﬂe´ and Autry
(2002) [27]
US Population-based
cohort 1985–1995
People with DD
ascertained at 10 years of
age from schools,
hospitals, other health
and social services, total
1584withDD aged 10–19
of whom 67% had ‘mental
retardation’. 34% had
epilepsy, number with ID
and epilepsy ns
Epilepsy, ns ns. 181 ‘epilepsy
multiple’ (has
epilepsy as well
as an additional
DD). 16 deaths
354 ‘epilepsy isolated’
(has epilepsy but no
additional DD), 3
deaths
General
population
SMRMR Epilepsy and additional DD
13.2 (7.6, 21.5),
Epilepsy but no additional DD
1.5 (0.3, 4.3)
Derby et al.
(1996) [31]
UK sample
authors US
Nested case-control
study 1989–1992
Those with refractory
epilepsy under 50 years
of age identiﬁed in
General Practice Research
Database (GPRD) (>4
million people registered
with GP) – ID those with
computer recorded
history of ID
Refractory;
received
prescriptions for
two or more AEDs
within 30 days of
each other
ns (two exposed
cases)
Total sample 4150,
total 15 SUDEP
Those in
sample
without ID
Relative
risk
SUDEP 1.4 (0.3, 8.0)
(Paper uses acronym ‘SUD’
but criteria used are
consistent with criteria for
SUDEP)
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Forsgren et al.
(1996) [18]
Sweden Prospective cohort
1987–1992
All registered with Board
for Provision & Services
to the Mentally Retarded
(BPSMR) in one province,
almost total ID
population in study area.
Total sample of 1478.
Males 821, females 657.
All levels of ID and ages.
Of these 296 with active
epilepsy
Active epilepsy.
Last SZ in last 5
years and/or on
AEDs
296 of whom
30 deaths
ID without epilepsy
1182 of whom 94
deaths
General
population
SMR Entire ID sample 2.0 (1.7, 2.3).
ID with epilepsy 5.0 (3.3, 7.5)
ID, epilepsy and CP 5.8 (3.4,
9.8).
SZ free in preceding year 2.0
(0.9, 4.7)
SZ weekly or fewer 4.7 (2.8,
7.9),
SZ more than weekly 16.8
(10.7, 26.5).
Partial SZ without SZ
secondarily generalised 3.7
(1.0, 13.6)
SZ secondarily generalised
5.0 (2.3, 11.0)
SZ generalised from onset 8.1
(5.7, 11.5)
Hermon
et al. (2001) [32]
England and
Scotland
Cohort study,
mortality followed
up to July 1997
1425 persons with DS
born before 1990
identiﬁed from records
of ﬁve collaborating
genetic units in England
and Scotland, total 346
deaths
ICD 9 – cause of
death epilepsy
(code 345)
ns, focus is
epilepsy as
cause of
death;
8 deaths
General population General
population
SMR Epilepsy as cause of death
17.3 (7.4, 34.0)
Hill et al.
(2003) [38]
Sweden and
Denmark
Hospitalisation data
linked to registries of
mortality and cancer
for thosewith diagnosis
of DS at discharge
1965–1993 Sweden
and 1977–1989
Denmark. Follow-up
to end 1993
Combined cohort of
4872 from Sweden
and Denmark with
hospital discharge
diagnosis of DS who
survived at least 12
months after date of
discharge, total 742
deaths
ICD 9 – cause of
death epilepsy
(code 345)
ns – focus is
epilepsy as
cause of
death;
9 deaths
General population General
population
SMR Epilepsy as cause of death
30.4 (13.9, 57.7)
Kiani et al.
(2014) [12]
England Retrospective cohort
1993–2010, epilepsy
related deaths
identiﬁed, case notes
of 20 SUDEP cases
investigated
5391 adults (20+)
with ID on the
Leicestershire
Intellectual Disability
Register database (LIDR)
of whom 1027 had
epilepsy (19%)
Diagnosis of
epilepsy
1027, total
244 all cause
deaths,
26 deﬁnite or
probable
SUDEP
Population approx
700,000; 607 deaths
potentially from
epilepsy; 83
deﬁnite or
probable SUDEP
General
population
of Leicester
City,
Leicester-shire
and Rutland
SMR Men with ID 2.2 (2.0, 2.4)
Women with ID 2.8 (2.5, 3.1).
Men with ID and epilepsy 3.2
(2.7, 3.8)
Women with ID and epilepsy
5.6 (4.6, 6.7)
SUDEP men with ID 37.6
(21.9, 60.2)
SUDEP women with ID 52.0
(23.8, 98.8)
Mo¨lsa¨ (1994) [34] Finland Cohort followed
for 20 years
1971–1991
212 Inpatients and 217
outpatients of a centre
for ‘mentally
handicapped’, 53% and
54% with epilepsy
respectively. All ages and
frommild to profound ID.
Total 88 deaths, 53
inpatients and 35
outpatients
Epilepsy yes/no 229c (approx;
no of deaths ns)
Without epilepsy 220c
(approx; no of deaths
ns)
Those without
epilepsy in
sample
Hazard
ratioRR
Outpatients 1.79 (0.76, 4.25),
Inpatients 0.87 (0.48, 1.61)
Outpatients subdivided by
type of residence, for those in
hostels risk of death due to
status epilepticus more than
doubled
Nashef et al.
(1995) [33]
England Cohort enrolled at
special school 1970–
1993, follow-up
included time after
leaving school
310 pupils with epilepsy
and ID at special
residential school for
children and adolescents
with epilepsy and ID
Most had severe
epilepsy, most
more than one
seizure a week
310 of whom
28 deaths,
14 of which
SUDEP
General population General
population
SMR All cause 15.9 (10.6, 23.0)
All 14 sudden deaths
occurred when the pupils
were not under the close
supervision of the school and
most were unwitnessed
(incidence 1:295/year)
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Table 2 (Continued )
Author Country Design and study
period
Sample description Epilepsy
deﬁnition
Sample size
ID and epilepsy
Sample size
other group
Comparison
group
Statistic Results (and 95%
conﬁdence interval).
All cause mortality unless
otherwise stated
Nickels
(2012) [28]
US Review of records of
population-based
cohort of children with
epilepsy 1980–2009
All children age 1 month
to 17 years diagnosed
with epilepsy while
resident in one County
(n=467). ‘Abnormal
cognitive function’ in 192
(109mild tomoderate ID;
83 severe ID)
Diagnosed with
new-onset
epilepsy; being
predisposed to
unprovoked
seizures
192 of whom
15 died
275 of whom 1 died Those without
ID in sample
Hazard
ratio
20.86 (2.76, 157.97)
In multivariable Cox
regression model only
abnormal neurological
examination remained
statistically signiﬁcant
Ohwada et al.
(2013) [39]
Japan Retrospective cohort
1984–2007
316 people (ages 18–69)
living in an institution
where 90% judged to have
severe ID. Excludes those
with severe motor
disabilities. Total 44
deaths
Presence or
absence of epilepsy
85 (deathsns) 231c (deaths ns) Those without
epilepsy in
sample
Hazard
ratio
2.39 (1.17, 4.92)
Multivariate analysis with
forced procedures HR 2.79
(1.21, 6.41)
Patja et al.
(2000) [35]
Finland Prospective cohort
1963–1997
Nationwide population-
based sample of 2366
people with ID with 35
year follow-up (61 689
person years). 1108 died
Epilepsy yes/no ns ns Those without
epilepsy
in sample
Hazard
ratioRR
Cox regression found
epilepsy was associated with
reduced survival for the
following:
2–9 years old in 1963 ns
(0.38, 0.84)
10–19-years old in 1963 ns
(0.10, 0.81)
Sillanpa¨a¨ and
Shinnar
(2010) [36]
Finland Prospective cohort
1964–2002
All children <16 yrs in
catchment area of a
University Hospital in
1964 with a diagnosis of
epilepsy (n=245),
number with ‘severe
cognitive impairment’
not stated
At least 2
unprovoked SZ;
classiﬁcation based
on ILAE
ns Total sample 245,
number with ID not
stated, 60 deaths
Those
without
severe
cognitive
impairment
in sample
Hazard
ratioRR
For those with remote
symptomatic epilepsy
(n=123 of whom 45 deaths),
severe cognitive impairment
was associated with
increased mortality 4.1 (2.0,
8.3)
Only lack of 5-year terminal
remission signiﬁcant in
multivariate analysis
Strauss et al.
(2003) [29]
(see also Day
et al., 2005 [25])
US Retrospective analysis
of records 1988–1999
People with mild DD
receiving services from
State of California, 71%
with ‘other DD’ of whom
majority had mild or
moderate ID. Excluded if
unable to walk well alone
at least 20 feet and
balance well, unable to
climb stairs without
support, severe or
profound ID.
Degenerative conditions
excluded.
Remote
symtomatic
epilepsy, idiopathic
epilepsy excluded
8156 of
whom 266
deaths
(some of
sample not
ID)
72,526 without
epilepsy of whom 1257
deaths (some of sample
not ID)
Those without
epilepsy in
sample
SMR Epilepsy no SZ in last year 1.1
(0.8, 1.5)
Seizures not GTC in last year
2.4 (1.9, 3.0),
GTC seizures in last year 2.9
(2.4, 3.4),
Status epilepticus in last year
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with no history of epilepsy
had an SMR of 1.7 (ns)
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J. Robertson et al. / Seizure 29 (2015) 123–133 129disabilities (excluding those with severe motor disabilities), the
hazard ratio for those with epilepsy compared to those without
was 2.39 (95% CI 1.17, 4.92) [39]. This remained signiﬁcant in a
multivariate analysis with a hazard ratio of 2.79 (95% CI 1.21, 6.41).
In a nationwide population-based sample, epilepsy was associated
with reduced survival in those who were aged 2–9 in 1962 (hazard
ratio 95% CI 0.38, 0.84, point estimate not stated) and those who
were aged 10–19 in 1962 (hazard ratio 95% CI 0.10, 0.81, point
estimate not stated) [35]. Finally, one study gives a hazard ratio of
2.29 (95% CI 1.50, 3.48) for those with epilepsy compared to those
without epilepsy in a cohort of people with Down syndrome aged
45 or more [37]. However, in multivariate survival analysis, age,
presence of dementia, and mobility restrictions were the most
important predictors of mortality.
3.5. All cause mortality in cohorts with epilepsy: comparison of those
with or without intellectual disabilities
In other studies, ﬁgures are given for cohorts of people with
epilepsy depending on whether or not they have an intellectual
disability. For those with epilepsy and an additional developmen-
tal disability (including but not necessarily intellectual disabilities)
the all cause SMR (compared to the general population) was 13.2
(95% CI 7.6, 21.5); for those with epilepsy and no other
developmental disability the SMR was 1.5 (95% CI 0.3, 4.3) [27].
In a population-based cohort of children with epilepsy, the hazard
ratio for those with intellectual disability compared to those with
epilepsy without intellectual disability was 20.86 (95% CI 2.76,
157.97) although only abnormal neurological examination was
statistically signiﬁcant in a multivariate model [28]. Similarly, for
those with remote symptomatic epilepsy the hazard ratio for those
with severe cognitive impairment was 4.1 (95% CI 2.0, 8.3) [36].
However, only lack of 5-year terminal remission was signiﬁcant in
multivariate analysis.
3.6. Causes of death
A small number of studies have considered speciﬁc causes of
death. One study looked at causes of death in people with mild
developmental disabilities (excluding those unable to walk well or
with degenerative conditions) and remote symptomatic epilepsy
which was noted to be epilepsy occurring in persons with
developmental delay or identiﬁed brain lesions and excluding
idiopathic epilepsy. Ratio SMRs were obtained for those with
epilepsy compared to those without epilepsy in the cohort for
numerous causes of death including: epilepsy/seizures 53.1 (95%
CI 28.0, 101.0); convulsions 25.2 (95% CI 11.7, 54.2); brain cancer
5.2 (95% CI 2.2, 12.1); accidents 2.7 (95% CI 1.9, 3.7); respiratory
diseases 1.7 (95% CI 1.2, 2.5) including aspiration pneumonia and
accidental inhation 3.0 (95% CI 1.5, 6.0); suicide 1.5 (95% CI 0.3,
6.5); and circulatory diseases 1.3 (95% CI 1.0, 1.7) [25]. Accidental
drowning was noted to be the single most signiﬁcant cause of
accidental death. The ratio SMR for accidental drowning, which
was included as part of the total accidents ﬁgures, was 12.8 (95% CI
7.0, 23.2). The ratio SMR for accidental drowning in those with
recent seizures was 15.8 (95% CI 7.2, 34.7). Compared to the
general population, the SMR for accidental drowning for those with
recent seizures was 35.9 (95% CI not stated) compared to 2.3 (95%
CI not stated) for those with no history of epilepsy. The authors
note that the excess numbers of deaths due to some causes (e.g.
seizures, aspiration, and accidental drowning) must at least in part
be attributable to epilepsy. For suicide, the SMR compared to the
general population was 0.3 (95% CI not stated) for those with
epilepsy and 0.2 for those without epilepsy. Finally, two studies
have looked at epilepsy as a cause of death in people with Down
syndrome compared to the general population, with one reporting
Records idenﬁe d through  
database  searchin g 
(n =  1332 ) 
Records aer  dup licates removed  
(n =  1099 ) 
Selected based on 
abstract and tle  (n =144) 
d
Excluded  based on abstract and tle (n=955) 
Arcles asses sed as   
eligible for inclusion 
(n = 13 ) 
Arcles idenﬁed from other 
sources (n = 3) 
Stu dies includ ed in 
tabulaon 
(n = 16  ) 
No stu die s suitable for 
meta-analysis 
(n =  0) 
Dup licates (n = 233 ) 
Excluded following consi deraon 
of full  text (n = 131) 
Fig. 1. Flowchart of study.
J. Robertson et al. / Seizure 29 (2015) 123–133130a SMR of 17.3 (95% CI 7.4, 34.0) [32] and one reporting a SMR of
30.4 (95% CI 13.9, 57.7) [38].
3.6.1. SUDEP
SUDEP as a cause of death is considered in a small number of
studies. In a sample from England, SMRs for SUDEP in people with
intellectual disabilities compared to the general population were
37.6 (95% CI 21.9, 60.2) for men and 52.0 (95% CI 23.8, 98.8) for
women [12]. A study of pupils at one school for pupils with severe
epilepsy and intellectual disabilities found an incidence of SUDEP
of 1:295/year [33]. It was noted that all 14 cases of SUDEP occurred
when the pupils were not under the close supervision of the school
and most were unwitnessed. In a study of those with refractory
epilepsy aged under 50, the relative risk of SUDEP was 1.4 (95% CI
0.3, 8.0) for those with a computer recorded history of intellectual
disabilities compared to those without [31]. Finally, for patients at
three epilepsy centres intellectual disability was a risk factor for
SUDEP after adjustment for seizure frequency (odds ratio 4.6 (95%
CI 1.2, 18.0)) [30].
4. Discussion
People with intellectual disabilities have an elevated risk of
death compared to the general population, and the studies
reviewed here indicate that this risk is elevated further in those
who have co-occurring epilepsy. The risk of death in people with
intellectual disabilities and epilepsy has been found to be greater
than in the general population by between 3.2 times for men on the
Leicestershire Intellectual Disability Register [12] and 16.8 times
for those having seizures more than weekly [18]. In comparison,the pooled estimate for mortality in cohorts of people with
epilepsy generally has been given as 3.3 (95% CI 2.83, 3.92) [10].
However, there are only four studies which provide a comparative
statistic for those with intellectual disabilities and epilepsy
compared to the general population [18,25,12,33].
In a number of studies comparing mortality in people with
intellectual disabilities and epilepsy to those with intellectual
disabilities without epilepsy in the same cohort, the risk of death
has been found to be two or more times greater [39,25,37],
although in the latter study only dementia, age at baseline and
restricted mobility were signiﬁcant in multivariate analysis.
Further, the risk appears to be associated with seizure type and
frequency with those who had not had a seizure in the last year not
having an elevated risk of mortality [29].
For studies involving cohorts of people with epilepsy,
increased risk for those with intellectual disabilities has been
reported [27,28]. However, in one of these studies, the risk
associated with intellectual disabilities was not signiﬁcant in
multivariate analysis, with abnormal neurological examination
being the only signiﬁcant factor [28]. Similarly, severe cognitive
impairment was associated with increased risk in those with
remote symptomatic epilepsy but on multivariate analysis only
lack of 5 year terminal remission was signiﬁcant [36]. This
suggests that, although mortality in those with intellectual
disabilities and epilepsy is signiﬁcantly elevated, some of this
excess is related to underlying conditions, rather than epilepsy per
se. As noted in a previous review, the higher mortality in those
with intellectual disabilities and epilepsy is partly due to epilepsy
being a marker of the severity of disability, and the severity of
disability being a predictor of mortality [40].
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noted that in the absence of a controlled comparison, it may not be
possible to separate the effect of epilepsy on mortality from the
effect due to the underlying condition [29]. To address this, Strauss
et al. [29] included only those with mild developmental disabilities
with minimal motor dysfunction who did not have degenerative
conditions. Based on a sample of over 80 thousand, they conclude
that epilepsy per se is associated with an increased mortality rate,
with the increased mortality risk being evident mainly in those
with ongoing seizures.
4.1. Causes of death
For people with mild developmental disabilities and remote
symptomatic epilepsy, the risk of death related to drowning in
those with epilepsy compared to those without epilepsy in the
cohort was 12.8 times higher [25]. Compared to the general
population, the SMR for drowning was 28.7 for those with remote
symptomatic epilepsy, increasing to 35.9 for those with recent
seizures. This compared to 2.3 for those with no history of epilepsy.
In the general population of people with epilepsy, the SMR for
drowning has been estimated as 18.7 (95% CI 15.0, 23.1) in a meta-
analysis of 51 cohorts [11]. These ﬁgures suggest that the risk of
drowning may be greater for people with mild developmental
disabilities and epilepsy than for the general population of people
with epilepsy, although this is based on just one study in which the
95% conﬁdence interval around the point estimate is not given.
Over the period 1993 to 2010, SUDEP was the second most
common cause of death among adults with epilepsy and
intellectual disabilities on the Leicestershire Intellectual Disability
Register [12]. Twenty-six people with intellectual disabilities died
from probable or deﬁnite SUDEP. The SMRs for SUDEP in adults
with intellectual disabilities were 37.6 for men and 52.0 for
women. The authors acknowledge that this is partly attributable to
the higher prevalence of epilepsy among people with intellectual
disabilities compared to the general population (the prevalence
being 19% in the cohort) but that even taking this into account,
people with intellectual disabilities appear to be disproportion-
ately disadvantaged. Similarly, intellectual disability has been
found to be a risk factor for SUDEP even after adjusting for seizure
frequency [30]. However, for those with refractory epilepsy on the
General Practice Research Database (GPRD, a database including
over 4 million people registered with a GP in the UK), the relative
risk of SUDEP was not signiﬁcantly increased in people with a
history of intellectual disability [31]. The authors acknowledge
that with a small number of sudden deaths, conﬁdence intervals
are wide and that ascertainment of intellectual disability may not
have been complete.
Finally, Day et al. [25] found that in people with developmental
disabilities and remote symptomatic epilepsy death rates were
elevated for a number of causes including aspiration pneumonia.
However, the rate for suicide was lower than that for the general
population (although the conﬁdence interval for this estimate is
not given). Overall, in relation to cause of death in people with
intellectual disabilities and epilepsy, there is a need for more
research on cause of death and to facilitate this there is a need for
better, detailed recording of death so that cause of death can be
determined with some certainty.
4.2. Limitations
There are a number of limitations to this review. Whilst
studies were identiﬁed from a range of countries, the review is
restricted to English language publications. Very little informa-
tion was identiﬁed regarding mortality for people with
intellectual disabilities and epilepsy in low and middle income(LAMI) countries. However, this is not surprising as there is little
information available regarding mortality for people with
epilepsy as a whole from LAMI countries. This lack of data
has been attributed to the fact that in LAMI countries, incidence
studies are difﬁcult, death certiﬁcates are not very reliable,
autopsies are not easy to obtain, and the cause of death is not
usually known with certainty [41].
The review has included studies relating to mortality in people
with intellectual disabilities and epilepsy generally but has only
included the most common syndrome associated with intellectual
disability (Down syndrome). People with intellectual disabilities
are a highly heterogeneous group. Whilst all have a signiﬁcant
general impairment in intellectual functioning that is acquired
during childhood, they differ in relation to the cause and severity
of the intellectual disability which may result from a complex
interaction between biomedical, social, behavioural and educa-
tional factors [17]. Further, life expectancy can vary markedly
between speciﬁc syndromes associated with intellectual dis-
abilities. For example, mucopolysaccharidosis type III (MPS III,
Sanﬁlippo syndrome) is associated with early death, generally
during the second or third decade of life [42], whilst life
expectancy in fragile X syndrome is not greatly reduced [43].
Future reviews could consider the issue of mortality in other
syndromes that are associated with intellectual disabilities. It is
evident that research related to epilepsy in such syndromes,
although not necessarily in relation to mortality, does exist (e.g.
[44]).
All data were extracted by one reviewer and extraction of
data by two reviewers independently would have reduced
the possibility of errors. Ideally, the same deﬁnition of epilepsy
should be used across studies to allow comparison of
mortality rates. However, the studies identiﬁed use a variety
of deﬁnitions of epilepsy as shown in Table 2. Further, for some
studies the conﬁdence intervals around point estimates are
extremely wide.
Finally, many of the studies include cohorts for time periods
that preceded the development of more recent anti-epileptic drugs
(AEDs). It has been noted that after a 15 year period with no new
treatments, ﬁve drugs for epilepsy were approved from 1993 to
1997 [45]. As such, the relevance of early cohorts to current
practice may be restricted. As poor seizure control appears to be a
risk factor for mortality, future studies may show a diminished risk
of mortality due to wider variety of treatment options.
5. Conclusion
The evidence base identiﬁed for this review is small and further
research is needed to substantiate some of the ﬁndings reported
here. However, the evidence suggests that people with intellectual
disabilities and epilepsy do have a substantially increased risk of
mortality, particularly where seizures are ongoing. It is important
that services are equipped with the information and skills needed
to manage epilepsy in this population. A recent report provides
information on reasonable adjustments that can be made to
improve epilepsy care for people with intellectual disabilities [46].
The ideas, information and examples of good practice in relation to
reasonable adjustments provided within this report should help
services improve provision for this highly prevalent condition and
potentially reduce the excess deaths associated with epilepsy in
people with intellectual disabilities.
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A.1. Medline and CINAHL
Limits: 1990; English; Human
(TI (learning N1 (disab* or difﬁcult* or handicap*)) OR TI (mental*
N1 (retard* or disab* or deﬁcien* or handicap* or disorder*)) OR TI
(intellectual* N1 (disab* or impair* or handicap*)) OR TI develop-
ment* N1 disab* OR TI (multipl* N1 (handicap* or disab*)) OR TI
‘‘Down* syndrome’’OR (MH ‘‘Developmental Disabilities/EP/MO’’) OR
(MH ‘‘Intellectual Disability+/EP/MO") OR (MH "mentally disabled
persons’’)) OR (AB (learning N1 (disab* or difﬁcult* or handicap*)) OR
AB (mental* N1 (retard* or disab* or deﬁcien* or handicap* or
disorder*)) OR AB (intellectual* N1 (disab* or impair* or handicap*))
OR AB development* N1 disab* OR AB (multipl* N1 (handicap* or
disab*)) OR AB ‘‘Down* syndrome’’)
AND
(MH ‘‘Epilepsy+/MO/EP’’) OR (TI epilep* OR TI seizure* OR TI
convulsi* OR AB epilep* OR AB seizure* OR AB convulsi*)
AND
(TI incidence OR TI prevalence OR TI mortality OR TI death OR AB
incidence OR AB prevalence OR AB mortality OR AB death) OR (MH
‘‘Incidence’’) OR (MH ‘‘Prevalence’’) OR (MH ‘‘Mortality+’’)
A.2. PsycINFO
Limits: 1990, Peer review, English, Exclude dissertations
DE ‘‘Epilepsy’’ OR DE ‘‘Epileptic Seizures’’ OR (DE ‘‘Seizures’’ OR DE
‘‘Audiogenic Seizures’’ OR DE ‘‘Epileptic Seizures’’ OR DE ‘‘Grand Mal
Seizures’’ OR DE ‘‘Petit Mal Seizures’’ OR DE ‘‘Status Epilepticus’’) OR
(TI epilep* OR TI seizure* OR TI convulsi* OR AB epilep* OR AB seizure*
OR AB convulsi*)
AND
(TI incidence OR TI prevalence OR TI mortality OR TI death OR AB
incidence OR AB prevalence OR AB mortality OR AB death) OR DE
‘‘Epidemiology’’ OR DE ‘‘death and dying’’ OR DE ‘‘mortality rate’’
AND
DE ‘‘Intellectual Development Disorder’’ OR DE ‘‘mental retarda-
tion’’ OR DE ‘‘developmental disabilities’’ OR (TI (learning N1 (disab*
or difﬁcult* or handicap*)) OR TI (mental* N1 (retard* or disab* or
deﬁcien* or handicap* or disorder*)) OR TI (intellectual* N1 (disab* or
impair* or handicap*)) OR TI development* N1 disab* OR TI (multipl*
N1 (handicap* or disab*)) OR TI ‘‘Down* syndrome’’) OR AB (mental*
N1 (retard* or disab* or deﬁcien* or handicap* or disorder*)) OR AB
(intellectual* N1 (disab* or impair* or handicap*)) OR AB develop-
ment* N1 disab* OR AB (multipl* N1 (handicap* or disab*)) OR AB
‘‘Down* syndrome’’
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